Persistent hyperplastic primary vitreous associated with septo-optic-pituitary dysplasia and schizencephaly.
Katsuya Lauer
A
A
Casey Eye Institute, Oregon Health Sciences Center, Portland 97201-4197, USA.
Balish
M J
MJ
Palmer
E A
EA
D000015:Abnormalities, Multiple / Q000175:diagnosis*; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000172:deficiency; D001921:Brain / Q000002:abnormalities*; D005124:Eye Abnormalities / Q000175:diagnosis*; D005654:Fundus Oculi; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D006965:Hyperplasia; D007231:Infant, Newborn; D008279:Magnetic Resonance Imaging; D009900:Optic Nerve / Q000002:abnormalities*; D010904:Pituitary Gland, Posterior / Q000002:abnormalities*; D012688:Septum Pellucidum / Q000002:abnormalities*; D013972:Thyrotropin / Q000172:deficiency; D013974:Thyroxine / Q000627:therapeutic use; D014822:Vitreous Body / Q000098:blood supply / Q000473:pathology*
D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D013974:Thyroxine; D006854:Hydrocortisone